S. J. van Hal

3.1k total citations · 2 hit papers
20 papers, 2.4k citations indexed

About

S. J. van Hal is a scholar working on Infectious Diseases, Clinical Biochemistry and Epidemiology. According to data from OpenAlex, S. J. van Hal has authored 20 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 13 papers in Clinical Biochemistry and 7 papers in Epidemiology. Recurrent topics in S. J. van Hal's work include Bacterial Identification and Susceptibility Testing (13 papers), Antimicrobial Resistance in Staphylococcus (13 papers) and Streptococcal Infections and Treatments (4 papers). S. J. van Hal is often cited by papers focused on Bacterial Identification and Susceptibility Testing (13 papers), Antimicrobial Resistance in Staphylococcus (13 papers) and Streptococcal Infections and Treatments (4 papers). S. J. van Hal collaborates with scholars based in Australia, United States and Greece. S. J. van Hal's co-authors include David L. Paterson, Thomas P. Lodise, Iain B. Gosbell, Slade O. Jensen, Björn A. Espedido, Vikram L. Vaska, Deborah Marriott, Vance G. Fowler, Adrian Brink and Emilio Bouza and has published in prestigious journals such as Clinical Microbiology Reviews, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

S. J. van Hal

20 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Predictors of Mortality in Staphylococcus aureus Bacteremia

2012 690 citations S. J. van Hal, Slade O. Jensen et al. Clinical Microbiology Reviews profile →
Systematic Review and Meta-Analysis of Vancomycin-Induced Nephrotoxicity Associated with Dosing Schedules That Maintain Troughs between 15 and 20 Milligrams per Liter

2012 479 citations S. J. van Hal, David L. Paterson et al. Antimicrobial Agents and Chemotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. J. van Hal Australia	18	1.7k	1.0k	655	553	438	20	2.4k
Leonard B. Johnson United States	27	2.0k 1.2×	887 0.9×	1.2k 1.8×	284 0.5×	435 1.0×	90	2.7k
Sebastiaan J. van Hal Australia	35	2.1k 1.2×	921 0.9×	1.3k 2.0×	429 0.8×	574 1.3×	110	3.3k
Barry Hafkin United States	20	1.4k 0.8×	631 0.6×	416 0.6×	410 0.7×	356 0.8×	35	2.0k
Peter K. Linden United States	25	1.4k 0.8×	932 0.9×	869 1.3×	414 0.7×	462 1.1×	34	2.8k
Mandy Wootton United Kingdom	28	1.2k 0.7×	940 0.9×	986 1.5×	419 0.8×	634 1.4×	92	2.8k
Wendy Munckhof Australia	20	1.0k 0.6×	635 0.6×	491 0.7×	395 0.7×	300 0.7×	42	1.7k
Jeff Alder United States	24	1.5k 0.9×	816 0.8×	771 1.2×	521 0.9×	838 1.9×	37	3.0k
Lata Venkataraman United States	25	1.9k 1.1×	940 0.9×	549 0.8×	289 0.5×	831 1.9×	34	2.5k
Mondell L. Beach United States	21	1.3k 0.8×	996 1.0×	750 1.1×	549 1.0×	652 1.5×	31	2.8k
Gary J. Moet United States	19	1.7k 1.0×	612 0.6×	1.1k 1.7×	232 0.4×	276 0.6×	24	2.3k

Countries citing papers authored by S. J. van Hal

Since Specialization

Citations

This map shows the geographic impact of S. J. van Hal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. J. van Hal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. J. van Hal more than expected).

Fields of papers citing papers by S. J. van Hal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. J. van Hal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. J. van Hal. The network helps show where S. J. van Hal may publish in the future.

Co-authorship network of co-authors of S. J. van Hal

This figure shows the co-authorship network connecting the top 25 collaborators of S. J. van Hal. A scholar is included among the top collaborators of S. J. van Hal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. J. van Hal. S. J. van Hal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bassetti, Matteo, Garyphallia Poulakou, Étienne Ruppé, et al.. (2017). Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approach. Intensive Care Medicine. 43(10). 1464–1475. 191 indexed citations

Young, Allison S., Miriam S. Welgampola, Peter McCluskey, et al.. (2017). Acute unilateral peripheral vestibulopathy in neurosyphilis. Journal of the Neurological Sciences. 378. 55–58. 8 indexed citations

Espedido, Björn A., Slade O. Jensen, & S. J. van Hal. (2014). Ceftaroline fosamil salvage therapy: an option for reduced-vancomycin-susceptible MRSA bacteraemia. Journal of Antimicrobial Chemotherapy. 70(3). 797–801. 11 indexed citations

Hal, S. J. van, et al.. (2014). Support for the EUCAST and revised CLSI fluconazole clinical breakpoints by Sensititre(R) YeastOne(R) for Candida albicans: a prospective observational cohort study. Journal of Antimicrobial Chemotherapy. 69(8). 2210–2214. 18 indexed citations

Hal, S. J. van & Vance G. Fowler. (2013). Is It Time to Replace Vancomycin in the Treatment of Methicillin-Resistant Staphylococcus aureus Infections?. Clinical Infectious Diseases. 56(12). 1779–1788. 81 indexed citations

Hal, S. J. van, Jason A. Steen, Björn A. Espedido, et al.. (2013). In vivo evolution of antimicrobial resistance in a series of Staphylococcus aureus patient isolates: the entire picture or a cautionary tale?. Journal of Antimicrobial Chemotherapy. 69(2). 363–367. 18 indexed citations

Tong, Steven Y. C., S. J. van Hal, Lloyd Einsiedel, Bart J. Currie, & John Turnidge. (2012). Impact of ethnicity and socio-economic status on Staphylococcus aureus bacteremia incidence and mortality: a heavy burden in Indigenous Australians. BMC Infectious Diseases. 12(1). 249–249. 49 indexed citations

Hal, S. J. van, Thomas P. Lodise, & David L. Paterson. (2012). The Clinical Significance of Vancomycin Minimum Inhibitory Concentration in Staphylococcus aureus Infections: A Systematic Review and Meta-analysis. Clinical Infectious Diseases. 54(6). 755–771. 402 indexed citations

Hal, S. J. van, David L. Paterson, & Thomas P. Lodise. (2012). Systematic Review and Meta-Analysis of Vancomycin-Induced Nephrotoxicity Associated with Dosing Schedules That Maintain Troughs between 15 and 20 Milligrams per Liter. Antimicrobial Agents and Chemotherapy. 57(2). 734–744. 479 indexed citations breakdown →

10.

Avent, Minyon, Vikram L. Vaska, Benjamin A. Rogers, et al.. (2012). Vancomycin therapeutics and monitoring: a contemporary approach. Internal Medicine Journal. 43(2). 110–119. 51 indexed citations

11.

Espedido, Björn A., Jason A. Steen, Joanne Mercer, et al.. (2012). Carriage of an ACME II Variant May Have Contributed to Methicillin-Resistant Staphylococcus aureus Sequence Type 239-Like Strain Replacement in Liverpool Hospital, Sydney, Australia. Antimicrobial Agents and Chemotherapy. 56(6). 3380–3383. 20 indexed citations

12.

Hal, S. J. van, Slade O. Jensen, Vikram L. Vaska, et al.. (2012). Predictors of Mortality in Staphylococcus aureus Bacteremia. Clinical Microbiology Reviews. 25(2). 362–386. 690 indexed citations breakdown →

13.

Hal, S. J. van, Michael C. Wehrhahn, Joanne Mercer, et al.. (2011). Performance of Various Testing Methodologies for Detection of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus in Bloodstream Isolates. Journal of Clinical Microbiology. 49(4). 1489–1494. 68 indexed citations

14.

Hal, S. J. van, S. C. A. Chen, Quoc Nguyen, et al.. (2009). Candidemia following solid organ transplantation in the era of antifungal prophylaxis: the Australian experience. Transplant Infectious Disease. 11(2). 122–127. 43 indexed citations

15.

Hal, S. J. van, et al.. (2008). MRSA detection: comparison of two molecular methods (BD GeneOhm® PCR assay and Easy-Plex) with two selective MRSA agars (MRSA-ID and Oxoid MRSA) for nasal swabs. European Journal of Clinical Microbiology & Infectious Diseases. 28(1). 47–53. 20 indexed citations

16.

Stark, Damien, S. J. van Hal, Gail Matthews, John Ellis, & Deborah Marriott. (2008). Invasive Amebiasis in Men Who Have Sex with Men, Australia. Emerging infectious diseases. 14(7). 1141–1143. 46 indexed citations

17.

Hal, S. J. van, Damien Stark, John Harkness, & Deborah Marriott. (2008). Candida dubliniensisMeningitis as Delayed Sequela of TreatedC. dubliniensisFungemia. Emerging infectious diseases. 14(2). 327–329. 27 indexed citations

18.

Hal, S. J. van, et al.. (2007). Methicillin-Resistant Staphylococcus aureus (MRSA) Detection: Comparison of Two Molecular Methods (IDI-MRSA PCR Assay and GenoType MRSA Direct PCR Assay) with Three Selective MRSA Agars (MRSA ID, MRSA Select , and CHROMagar MRSA) for Use with Infection-Control Swabs. Journal of Clinical Microbiology. 45(8). 2486–2490. 90 indexed citations

19.

Hal, S. J. van, K. Muthiah, Gail Matthews, et al.. (2007). Declining incidence of intestinal microsporidiosis and reduction in AIDS-related mortality following introduction of HAART in Sydney, Australia. Transactions of the Royal Society of Tropical Medicine and Hygiene. 101(11). 1096–1100. 23 indexed citations

20.

Hal, S. J. van, et al.. (2005). The role of transthoracic echocardiography in excluding left sided infective endocarditis in Staphylococcus aureus bacteraemia. Journal of Infection. 51(3). 218–221. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact